Sorrento Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Sorrento Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Sorrento Therapeutics Inc Strategy Report
- Understand Sorrento Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Sorrento Therapeutics Inc (Sorrento) focuses on the treatment of chronic cancer pain, besides immunology and infectious diseases. The lead product: ZTlido, proprietary G-MAB platform technology and focus on R&D are its strengths, even as lack of geographic diversification is a cause for concern to the company. The company could find opportunities through strategic acquisitons, growing incidence of cancer and rising healthcare expenditures for the US. However, it faces the challenges of stiff competition, government regulations and uncertain R&D outcomes.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer